| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.15 | 9e-06 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |